中国医药
中國醫藥
중국의약
CHINA MEDICINE
2009年
11期
900-902
,共3页
胆管癌%胆道引流
膽管癌%膽道引流
담관암%담도인류
Cholangiocarcinoma%Bile duct drainage
目的 分析肝门部胆管癌的治疗方法.方法 回顾性分析1998年4月至2007年12月32例肝门部胆管癌患者的治疗情况.结果 剖腹探查取活检7例(21.9%),平均存活时间为54 d.单纯胆管引流7例(21.9%),平均存活时间为5.6个月.手术切除加吻合18例(56.3%),平均存活时间为18.3个月.结论 影像学检查在肝门部胆管癌的诊断中具有重要价值;外科手术是治疗肝门部胆管癌最有效的方法;胆道引流亦可延长患者生存期;综合治疗是肝门部胆管癌治疗的方向.
目的 分析肝門部膽管癌的治療方法.方法 迴顧性分析1998年4月至2007年12月32例肝門部膽管癌患者的治療情況.結果 剖腹探查取活檢7例(21.9%),平均存活時間為54 d.單純膽管引流7例(21.9%),平均存活時間為5.6箇月.手術切除加吻閤18例(56.3%),平均存活時間為18.3箇月.結論 影像學檢查在肝門部膽管癌的診斷中具有重要價值;外科手術是治療肝門部膽管癌最有效的方法;膽道引流亦可延長患者生存期;綜閤治療是肝門部膽管癌治療的方嚮.
목적 분석간문부담관암적치료방법.방법 회고성분석1998년4월지2007년12월32례간문부담관암환자적치료정황.결과 부복탐사취활검7례(21.9%),평균존활시간위54 d.단순담관인류7례(21.9%),평균존활시간위5.6개월.수술절제가문합18례(56.3%),평균존활시간위18.3개월.결론 영상학검사재간문부담관암적진단중구유중요개치;외과수술시치료간문부담관암최유효적방법;담도인류역가연장환자생존기;종합치료시간문부담관암치료적방향.
Objective To observe surgical therapies of hepatic portal cholangiocarcinoma. Methods Thir-ty-two cases of hepatic portal cholangiocarcinoma between April 1998 and December 2007 were analyzed retrospec-tively. Results Average survival time of 7 cases (21.9%) of paunch ascertainment biopsy was 54 days. Average survival time of 7 cases(21.9%) of simplicity bile duct drainage was 5.6 months. Meanwhile average survival time of 18 cases (56.3%) of surgery excision and anastomosis were 18.3 months. Conclusions Image examination is of important value in diagnoses of hilar cholangiocarcinoma. Surgery is the primary method to treat hilar cholangiocarci-noma. Bile duct drainage may prolang patient's survival time and Iintegrative therapy is a direction of treating hilar cholangiocarcinoma.
